BioWorld

June 22, 1995

View Archived Issues

ARES-SERONO REPORTS POSITIVE PHASE II/III TRIAL DATA FOR ITS MS DRUG

Read More

VIAGENE LAUNCHES CANCER GENE THERAPY TRIALS

Read More

LA JOLLA RAISES $11M, SELLS MORE SHARES THAN EXPECTED

Read More

SWEDISH TEAM LIFTS HEM OF INVISIBILITY'S CLOAK ON EPSTEIN-BARR VIRAL

Read More

HOUSE NARROWLY REJECTS ATTEMPT TO RESTORE OTA FUNDING

Read More

$100M DEAL

Read More